Soluble VEGF receptor Flt1: The elusive preeclampsia factor discovered?

Journal of Clinical Investigation

Volumn 111, Issue 5, 2003, Pages 600-602

  Luttun, Aemout ^a   Carmeliet, Peter ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; EPHRIN; GROWTH FACTOR; PHOSPHOTRANSFERASE; TYROSINE KINASE RECEPTOR; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; CLINICAL TRIAL; ENDOTHELIUM; GLOMERULUS CAPILLARY; HUMAN; INTRACRANIAL HYPERTENSION; LIVER; NONHUMAN; NOTE; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL;

EID: 0037370337     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI18015     Document Type: Note

References (9)

1. Roberts, J.M., and Cooper, D.W. 2001. Pathogenesis and genetics of pre-eclampsia. Lancet. 357:53-56.
2. Pridjian, G., and Puschett, J.B. 2002. Preeclampsia. Part 1: clinical and pathophysiologic considerations. Obstet. Gynecol. Surv. 57:598-618.
3. Podjarny, E., Baylis, C., and Losonczy, G. 1999. Animal models of preeclampsia. Semin. Perinatol. 23:2-13.
4. Maynard, S.E., et al. 2003. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111:649-658. doi: 10.1172/JC1200317189.
5. Eremina, V., et al. 2003. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111:707-716. doi:10.1172/JC1200317423.
6. King, B.F. 1987. Ultrastructural differenciation of stromal and vascular components in early macaque placental villi. Am. J. Anat. 178:30-44.
7. Goldman-Wohl, D., and Yagel, S. 2002. Regulation of trophoblast invasion: from normal implantation to pre-eclampsia. Mol. Cell. Endocrinol. 187:233-238.
8. Zhou, Y., et al. 2002. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am. J. Patbol. 160:1405-1423.
9. Mattot, V., et al. 2002. Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. J. Am. Soc. Nephrol. 13:1548-1560.